Literature DB >> 7815544

A novel translational regulation function for the simian virus 40 large-T antigen gene.

P Rajan1, S Swaminathan, J Zhu, C N Cole, G Barber, M J Tevethia, B Thimmapaya.   

Abstract

Cells use the interferon-induced, double-stranded-RNA-dependent protein kinase PKR as a defense against virus infections. Upon activation, PKR phosphorylates and thereby inactivates the protein synthesis initiation factor eIF-2, resulting in the cessation of protein synthesis. Viruses have evolved various strategies to counteract this cellular defense. In this paper, we show that simian virus 40 (SV40) large-T antigen can antagonize the translational inhibitory effect resulting from the activation of PKR in virus-infected cells. Unlike the situation with other virus-host cell interactions, SV40 large-T antigen does not block the activation of PKR, suggesting that SV40 counteracts the cellular antiviral response mediated by PKR at a step downstream of PKR activation. Mutational analysis of large-T antigen indicates that a domain located between amino acids 400 and 600 of large-T antigen is responsible for this function. These results define a novel translational regulatory function for the SV40 large-T antigen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7815544      PMCID: PMC188643     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Mutations that allow human Ad2 and Ad5 to express late genes in monkey cells map in the viral gene encoding the 72K DNA binding protein.

Authors:  D F Klessig; T Grodzicker
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

2.  Nucleotide sequence analysis of two simian virus 40 mutants with deletions in the region coding for the carboxyl terminus of the T antigen.

Authors:  H Van Heuverswyn; C Cole; P Berg; W Fiers
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

3.  Binding of the adenovirus VAI RNA to the interferon-induced 68-kDa protein kinase correlates with function.

Authors:  G D Ghadge; S Swaminathan; M G Katze; B Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 4.  Adenovirus virus-associated RNA and translation control.

Authors:  M B Mathews; T Shenk
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 5.  Translational control in mammalian cells.

Authors:  J W Hershey
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

6.  Translational control by the Epstein-Barr virus small RNA EBER-1. Reversal of the double-stranded RNA-induced inhibition of protein synthesis in reticulocyte lysates.

Authors:  P A Clarke; N A Sharp; M J Clemens
Journal:  Eur J Biochem       Date:  1990-11-13

7.  Dissociation of Rb-binding and anchorage-independent growth from immortalization and tumorigenicity using SV40 mutants producing N-terminally truncated large T antigens.

Authors:  D L Thompson; D Kalderon; A E Smith; M J Tevethia
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

8.  Construction and analysis of viable deletion mutants of simian virus 40.

Authors:  T E Shenk; J Carbon; P Berg
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

9.  Activity of protein phosphatases against initiation factor-2 and elongation factor-2.

Authors:  N T Redpath; C G Proud
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

10.  Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein.

Authors:  J T Huang; R J Schneider
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

View more
  9 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

Review 2.  Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.

Authors:  Cyril X George; Zhiqun Li; Kristina M Okonski; Ann M Toth; Ying Wang; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

3.  Persistent borna disease virus infection confers instability of HSP70 mRNA in glial cells during heat stress.

Authors:  Makiko Yamashita; Wataru Kamitani; Hideyuki Yanai; Naohiro Ohtaki; Yohei Watanabe; Byeong-Jae Lee; Shoutaro Tsuji; Kazuyoshi Ikuta; Keizo Tomonaga
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Induction of type I interferon by adenovirus-encoded small RNAs.

Authors:  Tomoko Yamaguchi; Kenji Kawabata; Emi Kouyama; Ken J Ishii; Kazufumi Katayama; Takayuki Suzuki; Shinnosuke Kurachi; Fuminori Sakurai; Shizuo Akira; Hiroyuki Mizuguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-20       Impact factor: 11.205

Review 5.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Simian virus 40 large T overcomes p300 repression of c-Myc.

Authors:  Ghata Singhal; Ravi Kumar Kadeppagari; Natesan Sankar; Bayar Thimmapaya
Journal:  Virology       Date:  2008-08-01       Impact factor: 3.616

7.  Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death.

Authors:  Shirin Kazemi; Stavroula Papadopoulou; Suiyang Li; Qiaozhu Su; Shuo Wang; Akihiko Yoshimura; Greg Matlashewski; Thomas E Dever; Antonis E Koromilas
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  Adenovirus Vector-Derived VA-RNA-Mediated Innate Immune Responses.

Authors:  Mitsuhiro Machitani; Tomoko Yamaguchi; Kahori Shimizu; Fuminori Sakurai; Kazufumi Katayama; Kenji Kawabata; Hiroyuki Mizuguchi
Journal:  Pharmaceutics       Date:  2011-07-11       Impact factor: 6.321

9.  hTERT extends the life of human fibroblasts without compromising type I interferon signaling.

Authors:  Miles C Smith; Erica T Goddard; Mirna Perusina Lanfranca; David J Davido
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.